How Adoption of Artificial Intelligence Impacting Pharmaceutical Industry?
The global pharmaceuticals industry is in the throes of transition, both clinical trials and regulatory approvals have been challenged by the proliferation of specialized drugs catering to smaller patient groups. In order to boost results in drug discovery, clinical trials, and research and development, the pharmaceutical and life sciences companies are switching to robotic process control, artificial intelligence and machine learning. All these factors are anticipated to propel demand for artificial intelligence in pharmaceutical across the globe.
Artificial Intelligence Anticipated to Revolutionize Several Aspects of Pharmaceutical Industry
The way drugs are made, prescribed and ingested today will be standardized by artificial intelligence. Many facets of the pharmaceuticals and life sciences industry will also be revolutionized but will not heal sickness or replace physicians. Understanding the main aim of artificial intelligence, which is to improve human capability and accomplishment instead of challenging it, would dispel much of the technology’s concerns and put out its excellent ability to serve humanity.
Which Factors are Fueling AI in Pharmaceuticals Industry Growth?
• Growing Complexity of Modern Pharmacology
• Growing Demand for Viable Therapeutic Candidates
• Improves Overall R&D Productivity
• Concerns Associated with Rising Capital Requirements in Drug Discovery
• Increasing Awareness Related to Artificial Intelligence Among Pharmaceutical Manufacturers
Which Factors are Restraining Growth?
• Lack of Skilled Professionals
• Limited Availability of Datasets
UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.
To access the data contained in this document please email contactus@visiongain.com
How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.
Discover how to stay ahead
Our 350+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing AI in Pharmaceuticals Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, PEST Analysis, Porter’s Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Application
• Drug Discovery
• Precision Medicine
• Medical Imaging & Diagnostics
• Research
Technology
• Machine Learning
• Other Technologies
Offering
• Hardware
• Software
• Services
Deployment
• Cloud
• On-Premises
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 13 leading national markets:
By Region (Segmental Breakdown for All the Regions)
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– UK
– Italy
– Spain
– Rest of Europe
• Asia Pacific
– China
– Japan
– India
– Rest of Asia Pacific
• RoW
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for AI in Pharmaceuticals Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market– including company profiles for 16 of the major companies involved in the AI in Pharmaceuticals Market. Some of the companies profiled in this report include are Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Biosymetrics, Euretos, Insitro, Cyclica, Biovista, and OWKIN, INC.
Key Questions Answered by this Report
• What is the current size of the overall global AI in Pharmaceuticals market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall AI in Pharmaceuticals market over the next ten years?
• What are the main segments within the overall AI in Pharmaceuticals market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world AI in Pharmaceuticals? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Which are the leading companies and what are their activities, results, developments, and prospects?
• What are the main trends that will affect the world AI in Pharmaceuticals market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• How will the global AI in Pharmaceuticals market evolve over the forecasted period, 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is intended for everybody needing commercial analyses for the Global AI in Pharmaceuticals Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Artificial Intelligence (AI) in Pharmaceutical Market Report 2021-2031: Forecasts by Application (Drug Discovery, Precision Medicine, Medical Imaging & Diagnostics, Research), by Technology (Machine Learning, Other Technologies), by Offering (Hardware, Software, Services), by Deployment (Cloud, On-Premises) AND Regional and Leading National Market Analysis PLUS Analysis of Leading AI Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Artificial Intelligence in Pharmaceutical Market
1.2 Artificial Intelligence in Pharmaceutical Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Growing Complexity of Modern Pharmacology
3.1.2 Growing Demand for Viable Therapeutic Candidates
3.1.3 Improves Overall R&D Productivity
3.2 Restraints
3.2.1 Lack of Skilled Professionals
3.2.2 Limited Availability of Datasets
3.3 Opportunities
3.3.1 Adoption of AI in Drug Discovery
3.3.2 Rise of AI Across Biopharma
3.3.3 Cost Efficiency
3.3.4 Artificial Intelligence for Genomic Medicine
3.4 AI in Pharmaceuticals: Trends
3.4.1 Identifying Patients for Clinical Trials
3.4.2 Identifying Chemical Compounds
3.4.3 Machine Learning & Supply Chain
3.4.4 Machine Learning & Prescription Optimization
3.4.5 Data Science in Pharmaceutical Industry
3.5 SWOT Analysis
3.5.1 Strengths
3.5.2 Weaknesses
3.5.3 Opportunities
3.5.4 Threats
3.6 Industry analysis - Porter’s
3.6.1 Buyer Power
3.6.2 Supplier Power
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitute
3.6.5 Threat of New Entrants
3.7 Industry analysis – PEST Analysis
3.7.1 Political Factors Impacting AI in Pharmaceuticals
3.7.2 Economical
3.7.3 Social
3.7.4 Technological
4 Artificial Intelligence in Pharmaceutical Market by Application
4.1 Drug Discovery Segment Market Forecast, 2021-2031
4.1.1 Drug Discovery Segment Accounts for Majority of the Market Share
4.1.2 AI in Drug Screening to Fuel Market Growth
4.1.3 Recovery Scenarios (V, U, W, L)
4.2 Precision Medicine Segment Market Forecast, 2021-2031
4.2.1 Precision Medicine Segment to Witness Fastest Growth Rate Through 2031
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Medical Imaging & Diagnostics Segment Market Forecast, 2021-2031
4.3.1 Adoption of AI in Medical Imaging to Diagnose Wide Variety of Conditioons
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Research Segment Market Forecast, 2021-2031
4.4.1 Increasing Cost and Timelines for Drug Development to Fuel Adoption of AI in Research
4.4.2 Recovery Scenarios (V, U, W, L)
5 Artificial Intelligence in Pharmaceutical Market by Technology
5.1 Machine Learning Segment Market Forecast, 2021-2031
5.1.1 Burgeoning Applications of ML in Pharma are Glimmers of a Potential Future
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Other Technologies Segment Market Forecast, 2021-2031
5.2.1 Recovery Scenarios (V, U, W, L)
6 Artificial Intelligence in Pharmaceutical Market by Offering
6.1 Hardware Segment Market Forecast, 2021-2031
6.1.1 Recovery Scenarios (V, U, W, L)
6.2 Software Segment Market Forecast, 2021-2031
6.2.1 Recovery Scenarios (V, U, W, L)
6.3 Services Segment Market Forecast, 2021-2031
6.3.1 Recovery Scenarios (V, U, W, L)
7 Artificial Intelligence in Pharmaceutical Market by Deployment
7.1 Cloud Segment Market Forecast, 2021-2031
7.1.1 Cloud Segment Accounts for Majority of the Market Share
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 On-Premise Segment Market Forecast, 2021-2031
7.2.1 Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Artificial Intelligence in Pharmaceutical Market Forecasts 2021-2031
8.1 Global Artificial Intelligence in Pharmaceutical Market by Region Forecast 2021-2031
8.2 Recovery Scenarios (V, U, W, L)
9 North America Artificial Intelligence in Pharmaceutical Market
9.1 North America Artificial Intelligence in Pharmaceutical Market by Country, Forecast 2021-2031
9.2 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application
9.2.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
9.3 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology
9.3.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
9.4 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering
9.4.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
9.5 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
9.5.1 Recovery Scenarios (V, U, W, L): North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
9.6 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
9.6.1 U.S. Accounts for Majority of the Global AI in Pharmaceutical Market Share
9.6.2 Recovery Scenarios (V, U, W, L): U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
9.7 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
9.7.1 Canadian AI in Pharma to Witness Fastest Growth Rate Across North American Region
9.7.2 Recovery Scenarios (V, U, W, L): Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10 Europe Artificial Intelligence in Pharmaceutical Market
10.1 Europe Artificial Intelligence in Pharmaceutical Market by Country, Forecast 2021-2031
10.2 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application
10.2.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
10.3 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology
10.3.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
10.4 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering
10.4.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
10.5 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
10.5.1 Recovery Scenarios (V, U, W, L): Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
10.6 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.6.1 Collaboration Between Multinational Pharma and AI Driven Drug Discovery Companies to Fuel Regional Growth
10.6.2 Recovery Scenarios (V, U, W, L): UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.7 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.7.1 Germany Dominates the European AI in Pharmaceutical Market
10.7.2 Recovery Scenarios (V, U, W, L): Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.8 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.8.1 French AI in Pharma to Offer Lucrative Growth Opportunities
10.8.2 Recovery Scenarios (V, U, W, L): France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.9 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.9.1 Growing R&D Funding to Boost Italian AI in Pharmaceutical Market
10.9.2 Recovery Scenarios (V, U, W, L): Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.10 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.10.1 Recovery Scenarios (V, U, W, L): Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.11 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
10.11.1 Recovery Scenarios (V, U, W, L): Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11 Asia Pacific Artificial Intelligence in Pharmaceutical Market
11.1 Asia Pacific AI in Pharmaceutical to Witness Fastest CAGR Between 2021 to 2031
11.2 Asia Pacific Artificial Intelligence in Pharmaceutical Market by Country, Forecast 2021-2031
11.3 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application
11.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
11.4 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology
11.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
11.5 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering
11.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
11.6 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
11.6.1 Recovery Scenarios (V, U, W, L): Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
11.7 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.7.1 Japan AI in Pharma Accounts for Majority of the APAC Market
11.7.2 Recovery Scenarios (V, U, W, L): Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.8 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.8.1 Big Data and Artificial Intelligence to Have Significant Impact on Chinese Pharmaceutical Sector
11.8.2 Recovery Scenarios (V, U, W, L): China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.9 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.9.1 Indian AI in Pharmaceutical to Witness Fastest CAGR Over the Forecast Period
11.9.2 Recovery Scenarios (V, U, W, L): India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.10 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
11.10.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
12 RoW Artificial Intelligence in Pharmaceutical Market
12.1 RoW Artificial Intelligence in Pharmaceutical Market, Forecast 2021-2031
12.1.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031
12.2 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application
12.2.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031
12.3 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology
12.3.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031
12.4 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering
12.4.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031
12.5 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment
12.5.1 Recovery Scenarios (V, U, W, L): RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031
13 Company Profiles
13.1 Microsoft Corporation
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2015-2019
13.1.3.2 R&D Expenses, 2015-2019
13.1.3.3 Gross Profit, 2015-2019
13.1.3.4 Net Income, 2015-2019
13.1.3.5 EBDITA, 2015-2019
13.1.4 Product Benchmarking
13.1.5 Recent Developments, 2017-2020
13.2 NVIDIA Corporation
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2019
13.2.3.2 R&D Expenses, 2015-2019
13.2.3.3 Gross Profit, 2015-2019
13.2.3.4 Net Income, 2015-2019
13.2.3.5 EBDITA, 2015-2019
13.2.4 Product Benchmarking
13.2.5 Recent Developments, 2017-2020
13.3 IBM Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2019
13.3.3.2 R&D Expenses, 2015-2019
13.3.3.3 Gross Profit, 2015-2019
13.3.3.4 Net Income, 2015-2019
13.3.3.5 EBDITA, 2015-2019
13.3.4 Product Benchmarking
13.4 Alphabet Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2019
13.4.3.2 R&D Expenses, 2015-2019
13.4.3.3 Gross Profit, 2015-2019
13.4.3.4 Net Income, 2015-2019
13.4.3.5 EBDITA, 2015-2019
13.5 Atomwise, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.5.4 Recent Developments, 2017-2020
13.6 Deep Genomics
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Recent Developments, 2017-2020
13.7 Cloud Pharmaceuticals, Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.8 Insilico Medicine
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.8.4 Recent Developments, 2017-2020
13.9 BenevolentAI
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.9.4 Recent Developments, 2017-2020
13.10 Exscientia
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.10.4 Recent Developments, 2017-2020
13.11 Biosymetrics
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Recent Developments, 2019-2020
13.12 Euretos
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Recent Developments, 2017-2020
13.13 Insitro
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
13.13.4 Recent Developments, 2019-2020
13.14 Cyclica
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Product Benchmarking
13.14.4 Recent Developments, 2017-2020
13.15 Biovista
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Product Benchmarking
13.15.4 Recent Developments, 2017-2020
13.16 OWKIN, INC.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Product Benchmarking
13.16.4 Recent Developments, 2018-2020
14 Conclusion
List of Tables
Table 1 Global Artificial Intelligence in Pharmaceutical Market Snapshot, 2020 & 2031 (US$ million, CAGR %)
Table 2 Companies Involved in Some form of AI Genomics Activity
Table 3 Global AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global AI in Pharmaceutical Market for Drug Discovery Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 5 Global AI in Pharmaceutical Market for Drug Discovery Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global AI in Pharmaceutical Market for Drug Discovery Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global AI in Pharmaceutical Market for Drug Discovery Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 8 Global AI in Pharmaceutical Market for Drug Discovery Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 9 Global AI in Pharmaceutical Market for Precision Medicine Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 10 Global AI in Pharmaceutical Market for Precision Medicine Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global AI in Pharmaceutical Market for Precision Medicine Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global AI in Pharmaceutical Market for Precision Medicine Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 13 Global AI in Pharmaceutical Market for Precision Medicine Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 14 Global AI in Pharmaceutical Market for Medical Imaging & Diagnostics Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 15 Global AI in Pharmaceutical Market for Medical Imaging & Diagnostics Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global AI in Pharmaceutical Market for Medical Imaging & Diagnostics Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global AI in Pharmaceutical Market for Medical Imaging & Diagnostics Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 18 Global AI in Pharmaceutical Market for Medical Imaging & Diagnostics Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 19 Global AI in Pharmaceutical Market for Research Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 20 Global AI in Pharmaceutical Market for Research Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global AI in Pharmaceutical Market for Research Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global AI in Pharmaceutical Market for Research Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 23 Global AI in Pharmaceutical Market for Research Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 24 Global AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global AI in Pharmaceutical Market for Machine Learning Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 26 Global AI in Pharmaceutical Market for Machine Learning Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 27 Global AI in Pharmaceutical Market for Machine Learning Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 28 Global AI in Pharmaceutical Market for Machine Learning Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 29 Global AI in Pharmaceutical Market for Other Technologies Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 30 Global AI in Pharmaceutical Market for Other Technologies Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global AI in Pharmaceutical Market for Other Technologies Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global AI in Pharmaceutical Market for Other Technologies Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 33 Global AI in Pharmaceutical Market for Other Technologies Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 34 Global AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global AI in Pharmaceutical Market for Hardware Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 36 Global AI in Pharmaceutical Market for Hardware Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global AI in Pharmaceutical Market for Hardware Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global AI in Pharmaceutical Market for Hardware Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 39 Global AI in Pharmaceutical Market for Hardware Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 40 Global AI in Pharmaceutical Market for Software Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 41 Global AI in Pharmaceutical Market for Software Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global AI in Pharmaceutical Market for Software Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global AI in Pharmaceutical Market for Software Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 44 Global AI in Pharmaceutical Market for Software Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 45 Global AI in Pharmaceutical Market for Services Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 46 Global AI in Pharmaceutical Market for Services Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global AI in Pharmaceutical Market for Services Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global AI in Pharmaceutical Market for Services Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 49 Global AI in Pharmaceutical Market for Services Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 50 Global AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 51 Global AI in Pharmaceutical Market for Cloud Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 52 Global AI in Pharmaceutical Market for Cloud Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 53 Global AI in Pharmaceutical Market for Cloud Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 54 Global AI in Pharmaceutical Market for Cloud Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 55 Global AI in Pharmaceutical Market for Cloud Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 56 Global AI in Pharmaceutical Market for On-Premises Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 57 Global AI in Pharmaceutical Market for On-Premises Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 58 Global AI in Pharmaceutical Market for On-Premises Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 59 Global AI in Pharmaceutical Market for On-Premises Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 60 Global AI in Pharmaceutical Market for On-Premises Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 61 Global AI in Pharmaceutical Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 62 Global AI in Pharmaceutical Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 63 Global AI in Pharmaceutical Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 64 Global AI in Pharmaceutical Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 65 Global AI in Pharmaceutical Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): “L” Shaped Recovery
Table 66 North America AI in Pharmaceutical Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 67 North America AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 68 North America AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 69 North America AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 70 North America AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 71 North America AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 72 North America AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 73 North America AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 74 North America AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 75 North America AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 76 North America AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 77 North America AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 78 North America AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 79 North America AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 80 North America AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 81 North America AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 82 North America AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 83 North America AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 84 North America AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 85 North America AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 86 North America AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 87 U.S. AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 88 U.S. AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 89 U.S. AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 90 U.S. AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 91 U.S. AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 92 Canada AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 93 Canada AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 94 Canada AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 95 Canada AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 96 Canada AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 97 Europe AI in Pharmaceutical Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 Europe AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 99 Europe AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 100 Europe AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 101 Europe AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 102 Europe AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 103 Europe AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 104 Europe AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 105 Europe AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 106 Europe AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 107 Europe AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 108 Europe AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 109 Europe AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 110 Europe AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 111 Europe AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 112 Europe AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 113 Europe AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Europe AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Europe AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Europe AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 117 Europe AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 118 UK AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 119 UK AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 120 UK AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 121 UK AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 122 UK AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 123 Germany AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 124 Germany AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Germany AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Germany AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 127 Germany AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 128 France AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 129 France AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 130 France AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 131 France AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 132 France AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 133 Italy AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 134 Italy AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 135 Italy AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 136 Italy AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 137 Italy AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 138 Spain AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 139 Spain AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 140 Spain AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 141 Spain AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 142 Spain AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 143 Rest of Europe AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 144 Rest of Europe AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 145 Rest of Europe AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 146 Rest of Europe AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 147 Rest of Europe AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 148 Asia Pacific AI in Pharmaceutical Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 149 Asia Pacific AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 150 Asia Pacific AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 151 Asia Pacific AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 152 Asia Pacific AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 153 Asia Pacific AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 154 Asia Pacific AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 157 Asia Pacific AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 158 Asia Pacific AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 159 Asia Pacific AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 162 Asia Pacific AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 163 Asia Pacific AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 164 Asia Pacific AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 167 Asia Pacific AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 168 Japan AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 169 Japan AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 172 Japan AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 173 China AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 174 China AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 177 China AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 178 India AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 179 India AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 182 India AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 183 Rest of Asia Pacific AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 184 Rest of Asia Pacific AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Rest of Asia Pacific AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Rest of Asia Pacific AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 187 Rest of Asia Pacific AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 188 RoW AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 189 RoW AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 RoW AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 RoW AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 192 RoW AI in Pharmaceutical Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 193 RoW AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 194 RoW AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 RoW AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 RoW AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 197 RoW AI in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 198 RoW AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 199 RoW AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 200 RoW AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 201 RoW AI in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 202 RoW AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 RoW AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 RoW AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 RoW AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 206 RoW AI in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 207 RoW AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 RoW AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 RoW AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 RoW AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "W"" Shaped Recovery
Table 211 RoW AI in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ mn, AGR%, CAGR%): "L"" Shaped Recovery
Table 212 Microsoft Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 213 Microsoft Corporation: Product Benchmarking
Table 214 Microsoft Corporation: Recent Developments, 2017-2020
Table 215 NVIDIA Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 216 NVIDIA Corporation: Product Benchmarking
Table 217 NVIDIA Corporation: Recent Developments, 2017-2020
Table 218 IBM Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 219 IBM Corporation: Product Benchmarking
Table 220 Alphabet Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 221 Atomwise, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 222 Atomwise, Inc.: Product Benchmarking
Table 223 Atomwise, Inc.: Recent Developments, 2017-2020
Table 224 Deep Genomics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 225 Deep Genomics: Product Benchmarking (Pipeline)
Table 226 Deep Genomics: Recent Developments, 2017-2020
Table 227 Cloud Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 228 Cloud Pharmaceuticals, Inc.: Product Benchmarking
Table 229 Insilico Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 230 Insilico Medicine: Product Benchmarking
Table 231 Insilico Medicine: Recent Developments, 2017-2020
Table 232 BenevolentAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 233 BenevolentAI: Product Benchmarking
Table 234 BenevolentAI: Recent Developments, 2017-2020
Table 235 Exscientia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 236 Exscientia: Product Benchmarking
Table 237 Exscientia: Recent Developments, 2017-2020
Table 238 Biosymetrics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 239 Biosymetrics: Product Benchmarking
Table 240 Biosymetrics: Recent Developments, 2019-2020
Table 241 Euretos: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 242 Euretos: Product Benchmarking
Table 243 Euretos: Recent Developments, 2017-2020
Table 244 Insitro: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Insitro: Product Benchmarking
Table 246 Insitro: Recent Developments, 2019-2020
Table 247 Cyclica: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248 Cyclica: Product Benchmarking
Table 249 Cyclica: Recent Developments, 2017-2020
Table 250 Biovista: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 251 Biovista: Product Benchmarking
Table 252 Biovista: Recent Developments, 2017-2020
Table 253 OWKIN, INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254 OWKIN, INC.: Product Benchmarking
Table 255 OWKIN, INC.: Recent Developments, 2018-2020
List of Figures
Figure 1 Global Artificial Intelligence in Pharmaceutical Market: Market Segmentation
Figure 2 Global Artificial Intelligence in Pharmaceutical Market: SWOT Analysis
Figure 3 Porter’s Analysis
Figure 4 PEST Analysis
Figure 5 Global Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR %)
Figure 6 Global Artificial Intelligence in Pharmaceutical Market Share Forecast by Application, 2021, 2026, 2031 (%)
Figure 7 Global Artificial Intelligence in Pharmaceutical Market for Drug Discovery Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 8 Global Artificial Intelligence in Pharmaceutical Market for Drug Discovery Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 9 Global Artificial Intelligence in Pharmaceutical Market for Drug Discovery Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 10 Global Artificial Intelligence in Pharmaceutical Market for Drug Discovery Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 11 Global Artificial Intelligence in Pharmaceutical Market for Drug Discovery Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 12 Global Artificial Intelligence in Pharmaceutical Market for Precision Medicine Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 13 Global Artificial Intelligence in Pharmaceutical Market for Precision Medicine Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 14 Global Artificial Intelligence in Pharmaceutical Market for Precision Medicine Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 15 Global Artificial Intelligence in Pharmaceutical Market for Precision Medicine Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 16 Global Artificial Intelligence in Pharmaceutical Market for Precision Medicine Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 17 Global Artificial Intelligence in Pharmaceutical Market for Medical Imaging & Diagnostics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 18 Global Artificial Intelligence in Pharmaceutical Market for Medical Imaging & Diagnostics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 19 Global Artificial Intelligence in Pharmaceutical Market for Medical Imaging & Diagnostics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 20 Global Artificial Intelligence in Pharmaceutical Market for Medical Imaging & Diagnostics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 21 Global Artificial Intelligence in Pharmaceutical Market for Medical Imaging & Diagnostics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 22 Global Artificial Intelligence in Pharmaceutical Market for Research Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 23 Global Artificial Intelligence in Pharmaceutical Market for Research Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 24 Global Artificial Intelligence in Pharmaceutical Market for Research Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 25 Global Artificial Intelligence in Pharmaceutical Market for Research Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 26 Global Artificial Intelligence in Pharmaceutical Market for Research Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 27 Global Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR %)
Figure 28 Global Artificial Intelligence in Pharmaceutical Market Share Forecast by Technology, 2021, 2026, 2031 (%)
Figure 29 Global Artificial Intelligence in Pharmaceutical Market for Machine Learning Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 30 Global Artificial Intelligence in Pharmaceutical Market for Machine Learning Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 31 Global Artificial Intelligence in Pharmaceutical Market for Machine Learning Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 32 Global Artificial Intelligence in Pharmaceutical Market for Machine Learning Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 33 Global Artificial Intelligence in Pharmaceutical Market for Machine Learning Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 34 Global Artificial Intelligence in Pharmaceutical Market for Other Technologies Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 35 Global Artificial Intelligence in Pharmaceutical Market for Other Technologies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 36 Global Artificial Intelligence in Pharmaceutical Market for Other Technologies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 37 Global Artificial Intelligence in Pharmaceutical Market for Other Technologies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 38 Global Artificial Intelligence in Pharmaceutical Market for Other Technologies Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 39 Global Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR %)
Figure 40 Global Artificial Intelligence in Pharmaceutical Market Share Forecast by Offering, 2021, 2026, 2031 (%)
Figure 41 Global Artificial Intelligence in Pharmaceutical Market for Hardware Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 42 Global Artificial Intelligence in Pharmaceutical Market for Hardware Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 43 Global Artificial Intelligence in Pharmaceutical Market for Hardware Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 44 Global Artificial Intelligence in Pharmaceutical Market for Hardware Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 45 Global Artificial Intelligence in Pharmaceutical Market for Hardware Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 46 Global Artificial Intelligence in Pharmaceutical Market for Software Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 47 Global Artificial Intelligence in Pharmaceutical Market for Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 48 Global Artificial Intelligence in Pharmaceutical Market for Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 49 Global Artificial Intelligence in Pharmaceutical Market for Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 50 Global Artificial Intelligence in Pharmaceutical Market for Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 51 Global Artificial Intelligence in Pharmaceutical Market for Services Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 52 Global Artificial Intelligence in Pharmaceutical Market for Services Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 53 Global Artificial Intelligence in Pharmaceutical Market for Services Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 54 Global Artificial Intelligence in Pharmaceutical Market for Services Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 55 Global Artificial Intelligence in Pharmaceutical Market for Services Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 56 Global Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR %)
Figure 57 Global Artificial Intelligence in Pharmaceutical Market Share Forecast by Deployment, 2021, 2026, 2031 (%)
Figure 58 Global Artificial Intelligence in Pharmaceutical Market for Cloud Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 59 Global Artificial Intelligence in Pharmaceutical Market for Cloud Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 60 Global Artificial Intelligence in Pharmaceutical Market for Cloud Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 61 Global Artificial Intelligence in Pharmaceutical Market for Cloud Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 62 Global Artificial Intelligence in Pharmaceutical Market for Cloud Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 63 Global Artificial Intelligence in Pharmaceutical Market for On-Premise Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 64 Global Artificial Intelligence in Pharmaceutical Market for On-Premise Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 65 Global Artificial Intelligence in Pharmaceutical Market for On-Premise Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 66 Global Artificial Intelligence in Pharmaceutical Market for On-Premise Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 67 Global Artificial Intelligence in Pharmaceutical Market for On-Premise Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 68 Global Artificial Intelligence in Pharmaceutical Market Forecast by Region 2021-2031 (US$ million)
Figure 69 Global Artificial Intelligence in Pharmaceutical Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 70 Global Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 71 Global Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 72 Global Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 73 Global Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 74 North America Artificial Intelligence in Pharmaceutical Market Forecast by Country 2021-2031 (US$ million)
Figure 75 North America Artificial Intelligence in Pharmaceutical Market Share Forecast by Country: 2021, 2026, 2031 (%)
Figure 76 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 77 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 78 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 79 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 80 North America Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 81 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%)
Figure 82 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 83 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 84 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 85 North America Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 86 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%)
Figure 87 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 88 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 89 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 90 North America Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 91 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%)
Figure 92 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 93 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 94 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 95 North America Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 96 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 97 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 98 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 99 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 100 U.S. Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 101 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 102 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 103 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 104 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 105 Canada Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 106 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Country 2021-2031 (US$ million)
Figure 107 Europe Artificial Intelligence in Pharmaceutical Market Share Forecast by Country: 2021, 2026, 2031 (%)
Figure 108 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 109 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 110 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 111 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 112 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 113 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%)
Figure 114 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 115 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 116 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 117 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 118 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%)
Figure 119 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 120 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 121 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 122 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 123 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%)
Figure 124 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 125 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 126 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 127 Europe Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 128 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 129 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 130 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 131 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 132 UK Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 133 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 134 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 135 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 136 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 137 Germany Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 138 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 139 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 140 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 141 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 142 France Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 143 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 144 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 145 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 146 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 147 Italy Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 148 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 149 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 150 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 151 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 152 Spain Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 153 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 154 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 155 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 156 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 157 Rest of Europe Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 158 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Country 2021-2031 (US$ million)
Figure 159 Asia Pacific Artificial Intelligence in Pharmaceutical Market Share Forecast by Country: 2021, 2026, 2031 (%)
Figure 160 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 161 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 162 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 163 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 164 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 165 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%)
Figure 166 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 167 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 168 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 169 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 170 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%)
Figure 171 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 172 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 173 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 174 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 175 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%)
Figure 176 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 177 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 178 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 179 Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 180 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 181 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 182 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 183 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 184 Japan Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 185 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 186 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 187 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 188 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 189 China Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 190 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 191 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 192 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 193 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 194 India Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 195 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 196 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 197 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 198 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 199 Rest of Asia Pacific Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 200 RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million)
Figure 201 RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 202 RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 203 RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 204 RoW Artificial Intelligence in Pharmaceutical Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 205 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%)
Figure 206 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 207 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 208 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 209 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Application, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 210 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%)
Figure 211 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 212 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 213 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 214 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Technology, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 215 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%)
Figure 216 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 217 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 218 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 219 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Offering, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 220 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%)
Figure 221 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 222 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 223 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 224 RoW Artificial Intelligence in Pharmaceutical Market Forecast by Deployment, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 225 Microsoft Corporation: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 226 Microsoft Corporation: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 227 Microsoft Corporation: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 228 Microsoft Corporation: Net Income, 2015-2019 (US$ million, AGR%)
Figure 229 Microsoft Corporation: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 230 NVIDIA Corporation: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 231 NVIDIA Corporation: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 232 NVIDIA Corporation: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 233 NVIDIA Corporation: Net Income, 2015-2019 (US$ million, AGR%)
Figure 234 NVIDIA Corporation: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 235 IBM Corporation: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 236 IBM Corporation: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 237 IBM Corporation: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 238 IBM Corporation: Net Income, 2015-2019 (US$ million, AGR%)
Figure 239 IBM Corporation: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 240 Alphabet Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 241 Alphabet Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 242 Alphabet Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 243 Alphabet Inc.: Net Income, 2015-2019 (US$ million, AGR%)
Figure 244 Alphabet Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Companies Profiled in the Report
Alphabet Inc.
Atomwise, Inc.
BenevolentAI
Biosymetrics
Biovista
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Euretos
Exscientia
IBM Corporation
Insilico Medicine
Insitro
Microsoft Corporation
NVIDIA Corporation
OWKIN, INC.
List of Other Companies
3BIGS
3W Partners
6 Dimensions Capital
8VC
99andBeyond
A2A Pharmaceuticals
Abalone Bio
BioInvent International
Biomea Healthcare
BioMotiv
Bionano Genomics
C4X Discovery
Caffeinated Capital
Calibr
CARB-X
CareDx
CaroCure
Cyclica
Dante Labs
Data4cure
Dataspora
Datavant
Dyno Therapeutics
Echo Health Ventures
G3 Therapeutics
Galapagos
InfoChem
InnoPharmaScreen
Innophore
Innoplexus
Labcyte
LabGenius
LabKey
M12
MAbSilico
Macroceutics
Neuropore Therapies
NeuroTheryX
Qulab
Zastra
ZebiAI
List of Organizations
California Institute of Biomedical Research
Cambia Health Solutions
Cambridge Cancer Genomics
Cambridge Research Centre
CSIRO
Department of Health and Social Care
Healx
National Center for Advancing Translational Sciences (NCATS )
National Center for Biotechnology Information
National Center for Research and Development
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Aging (NIA)
National Institutes of Health
Royal Society of Chemistry
Society for Medicines Research
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
